Compounds
ID | Spectrum Quality | Annotated Name |
---|
COMPOUND NPA003046
PROPERTIES
NPAID | NPA003046 |
---|---|
CLUSTER ID | 1738 |
NODE ID | 1413 |
NAME | SB 253517 |
FORMULA | C30H50N2O9 |
MOLECULAR WEIGHT (Da) | 582.7350 |
ACCURATE MASS (Da) | 582.3516 |
ORIGIN ORGANISM TYPE | Bacterium |
ORIGIN GENUS | Pseudomonas |
ORIGIN SPECIES | fluorescens |
InChIKey | ACEGJCGROBMIPR-RECQNDHXSA-N |
InChI | InChI=1S/C30H50N2O9/c1-3-4-5-6-7-8-9-10-11-12-13-15-21(40-29-28(37)27(36)26(35)20(2)39-29)18-24(33)31-25(34)19-23-22-16-14-17-32(22)30(38)41-23/h19-22,26-29,35-37H,3-18H2,1-2H3,(H,31,33,34)/b23-19+/t20-,21-,22+,26-,27+,28+,29-/m0/s1 |
SMILES | CCCCCCCCCCCCC[C@@H](CC(=O)NC(=O)/C=C/1\[C@H]2CCCN2C(=O)O1)O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O)O |
ORIGINAL ISOLATION REFERENCE
CITATION | Thirkettle, J SB-253514 and analogues; novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. III. Biotransformation using naringinase Journal of Antibiotics 2000 53 (7) 733-735. | ||
---|---|---|---|
DOI | 10.7164/antibiotics.53.664 | PMID | 10994818 |